Supreme Court affirms Affinity, GIC's exit value on Kyobo Life

The ruling ends a five-year legal dispute between the Affinity Equity-led group and Kyobo Life

Kyobo Life Insurance's headquarters in Seoul
Kyobo Life Insurance's headquarters in Seoul
Si-On Park 2
2023-11-29 11:45:52 Ushire908@hankyung.com
Private equity

South Korea’s Supreme Court on Wednesday upheld the ruling that would allow the Affinity Equity Partners-led consortium, including Singapore’s GIC, to make a long-delayed exit from Kyobo Life Insurance Co. at more than 1.5 times their investment of 1.2 trillion won ($930 million).

Ending a five-year legal dispute between Kyobo and the investors, the highest court in South Korea cleared three accountants at Deloitte Anjin and two employees of Affinity Equity Partners of charges that they had unfairly inflated the value of unlisted Kyobo to help the group's divestment for hefty gains.

The Supreme Court’s decision affirmed the verdicts made by both district and appellate courts in Seoul, which rejected Kyobo’s complaint about the valuation.

The verdict will likely pave the way for the Affinity-led investors, which includes Baring Private Equity and IMM Private Equity, to finally exit from Kyobo after more than a decade.

Kyobo Life Insurance Chairman Shin Chang-jae
Kyobo Life Insurance Chairman Shin Chang-jae

PUT OPTION

Back in 2012, the Affinity-led consortium acquired a combined 24% stake in Kyobo for 1.2 trillion won from then Daewoo International Co., currently POSCO International Corp.

The stock purchase came with a put option, which allowed them to sell Kyobo shares back to Kyobo, including its Chairman Shin Chang-jae, if the insurer failed to go public by September 2015.

As its IPO has dragged on, the Affinity-led group in late 2018 decided to exercise the option, calling on Kyobo Life's top shareholder and Chairman Shin to buy back their shares at 410,000 won apiece. That is 1.65 times higher than their purchase price of 245,000 won.

Supreme Court affirms Affinity, GIC's exit value on Kyobo Life

LEGAL DISPUTE

The Kyobo chairman rejected the put option request and argued that the valuation was based on a falsified financial report in return for alleged bribes paid by the investor consortium.

The two sides have been in a legal dispute since 2018, while resorting to arbitration, which failed to settle the issue.

In the meantime, the Korea Exchange has held off its review of Kyobo’s IPO application pending a court decision.

Kybo’s family members control 36.37% of the insurer, including a 33.78% stake held by Chairman Shin, as of end-September.

Affinity Equity owns 9.05% of Kyobo Life, with Baring PE and IMM PE holding a 5.23% stake, respectively. GIC has a 4.5% stake in the Korean insurer.

Write to Si-On Park at Ushire908@hankyung.com
 

Yeonhee Kim edited this article
#KyoboLife #DeloitteAnjin #Deloitte #GIC #BaringPrivate Equity #IMMPrivateEquity #Koreasupremecourt #putoption

S.Korean auditors enjoy sharp pay rise under new laws

S.Korean auditors enjoy sharp pay rise under new laws

South Korean companies spent 2,447 hours for financial audits on average in 2021, up 44% on-year The average salary of accountants at Big Four accounting firms in South Korea has more than doubled over the past few years, as financial regulators continue to tighten accounting and auditing regul

Kyobo Life’s holding firm plan gains speed with Pavilion Asset acquisition

Kyobo Life’s holding firm plan gains speed with Pavilion Asset acquisition

(Courtesy of Kyobo Life Insurance) Kyobo Life Insurance Co. has completed the process to put a South Korea-based alternative asset investment company under its wing, a move that is expected to help the country’s third-largest life insurance firm diversify its business portfolio and expedi

Seoul court upholds Affinity's Kyobo Life valuation

Seoul court upholds Affinity's Kyobo Life valuation

Kyobo Life headquarters building in central Seoul A South Korean court on Thursday ruled in favor of Affinity Equity-led financial investors (FIs) in Kyobo Life Insurance Co., rejecting Kyobo's claim that the investors had unfairly inflated its valuation to sell their shares back to the unliste

Kyobo Life eyes 2022 IPO to end feud with investors

Kyobo Life eyes 2022 IPO to end feud with investors

Kyobo Life Insurance Co. on Tuesday applied for a preliminary review of its public listing with the Korea Exchange, three years after it canceled the IPO plan at the end of 2018 amid a thorny dispute with overseas investors.The IPO is expected to take place in the second half of next year at i

Kyobo Life resumes IPO push amid protracted dispute with investors

Kyobo Life resumes IPO push amid protracted dispute with investors

Kyobo Life Insurance headquarters in Seoul Kyobo Life Insurance Co., South Korea’s third-largest life insurer, is resuming its push for an initial public offering amid a protracted legal dispute with its major financial investors over their exercise of put option rights.The company said o

Affinity, GIC speed up exit efforts on Kyobo Life

Affinity, GIC speed up exit efforts on Kyobo Life

Kyobo Life Insurance headquarters in Seoul Singapore's GIC, Affinity Equity Partners, Baring Private Equity and IMM Private Equity have taken the next step toward their long-delayed exit from South Korea's unlisted Kyobo Life Insurance Co., after an international arbitration body's ruling faile

GIC, PEFs face further delays to Kyobo exit after ruling

GIC, PEFs face further delays to Kyobo exit after ruling

Singapore’s GIC, Canada's Ontario Teacher's Pension Plan (OTPP) and private equity firms, including Affinity Equity Partners, may need to endure a protracted process again to exit their decade-long investment of over 1.2 trillion won ($1 billion) in South Korea's Kyobo Life Insurance Co.

Affinity Equity-led group to exercise put option on $1.8 bn Kyobo Life shares

Affinity Equity-led group to exercise put option on $1.8 bn Kyobo Life shares

A consortium led by Affinity Equity Partners will push ahead with exercising their right to sell shares in South Korea’s Kyobo Life Insurance Co. Ltd. by the end of this month, which they estimate at 2 trillion won ($1.8 billion), frustrated by long delays in the insurer’s initial public offering, a
(* comment hide *}